BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 33832410)

  • 21. The Cosmetic Ingredient Review Program-Expert Safety Assessments of Cosmetic Ingredients in an Open Forum.
    Boyer IJ; Bergfeld WF; Heldreth B; Fiume MM; Gill LJ
    Int J Toxicol; 2017; 36(5_suppl2):5S-13S. PubMed ID: 29025345
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety assessment of isoparaffins as used in cosmetics.
    Johnson W; Bergfeld WF; Belsito DV; Hill RA; Klaassen CD; Liebler D; Marks JG; Shank RC; Slaga TJ; Snyder PW; Andersen FA
    Int J Toxicol; 2012; 31(6 Suppl):269S-95S. PubMed ID: 23283704
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety Assessment of Tocopherols and Tocotrienols as Used in Cosmetics.
    Fiume MM; Bergfeld WF; Belsito DV; Hill RA; Klaassen CD; Liebler DC; Marks JG; Shank RC; Slaga TJ; Snyder PW; Andersen FA; Heldreth B
    Int J Toxicol; 2018; 37(2_suppl):61S-94S. PubMed ID: 30235959
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety Assessment of Synthetic Fluorphlogopite as Used in Cosmetics.
    Becker LC; Bergfeld WF; Belsito DV; Hill RA; Klaassen CD; Liebler DC; Marks JG; Shank RC; Slaga TJ; Snyder PW; Andersen FA
    Int J Toxicol; 2015; 34(3 Suppl):43S-52S. PubMed ID: 26684795
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety Assessment of Monosaccharides, Disaccharides, and Related Ingredients as Used in Cosmetics.
    Fiume MM; Bergfeld WF; Belsito DV; Hill RA; Klaassen CD; Liebler DC; Marks JG; Shank RC; Slaga TJ; Snyder PW; Gill LJ; Heldreth B
    Int J Toxicol; 2019; 38(1_suppl):5S-38S. PubMed ID: 31170840
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Final report of the cosmetic ingredient review expert panel on the safety assessment of Polyisobutene and Hydrogenated Polyisobutene as used in cosmetics.
    Int J Toxicol; 2008; 27 Suppl 4():83-106. PubMed ID: 19101833
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety Assessment of Keratin and Keratin-Derived Ingredients as Used in Cosmetics.
    Burnett CL; Bergfeld WF; Belsito DV; Hill RA; Klaassen CD; Liebler DC; Marks JG; Shank RC; Slaga TJ; Snyder PW; Gill LJ; Heldreth B
    Int J Toxicol; 2021 Oct; 40(2_suppl):36S-51S. PubMed ID: 34514894
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety evaluation of cosmetics in the EU. Reality and challenges for the toxicologist.
    Pauwels M; Rogiers V
    Toxicol Lett; 2004 Jun; 151(1):7-17. PubMed ID: 15177635
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety Assessment of Saccharide Esters as Used in Cosmetics.
    Scott LN; Bergfeld WF; Belsito DV; Hill RA; Klaassen CD; Liebler DC; Marks JG; Shank RC; Slaga TJ; Snyder PW; Gill LJ; Heldreth B
    Int J Toxicol; 2021 Oct; 40(2_suppl):52S-116S. PubMed ID: 34514895
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Final report on the safety assessment of AloeAndongensis Extract, Aloe Andongensis Leaf Juice,aloe Arborescens Leaf Extract, Aloe Arborescens Leaf Juice, Aloe Arborescens Leaf Protoplasts, Aloe Barbadensis Flower Extract, Aloe Barbadensis Leaf, Aloe Barbadensis Leaf Extract, Aloe Barbadensis Leaf Juice,aloe Barbadensis Leaf Polysaccharides, Aloe Barbadensis Leaf Water, Aloe Ferox Leaf Extract, Aloe Ferox Leaf Juice, and Aloe Ferox Leaf Juice Extract.
    Cosmetic Ingredient Review Expert Panel
    Int J Toxicol; 2007; 26 Suppl 2():1-50. PubMed ID: 17613130
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alternative (non-animal) methods for cosmetics testing: current status and future prospects-2010.
    Adler S; Basketter D; Creton S; Pelkonen O; van Benthem J; Zuang V; Andersen KE; Angers-Loustau A; Aptula A; Bal-Price A; Benfenati E; Bernauer U; Bessems J; Bois FY; Boobis A; Brandon E; Bremer S; Broschard T; Casati S; Coecke S; Corvi R; Cronin M; Daston G; Dekant W; Felter S; Grignard E; Gundert-Remy U; Heinonen T; Kimber I; Kleinjans J; Komulainen H; Kreiling R; Kreysa J; Leite SB; Loizou G; Maxwell G; Mazzatorta P; Munn S; Pfuhler S; Phrakonkham P; Piersma A; Poth A; Prieto P; Repetto G; Rogiers V; Schoeters G; Schwarz M; Serafimova R; Tähti H; Testai E; van Delft J; van Loveren H; Vinken M; Worth A; Zaldivar JM
    Arch Toxicol; 2011 May; 85(5):367-485. PubMed ID: 21533817
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Final report on the safety assessment of Glycyrrhetinic Acid, Potassium Glycyrrhetinate, Disodium Succinoyl Glycyrrhetinate, Glyceryl Glycyrrhetinate, Glycyrrhetinyl Stearate, Stearyl Glycyrrhetinate, Glycyrrhizic Acid, Ammonium Glycyrrhizate, Dipotassium Glycyrrhizate, Disodium Glycyrrhizate, Trisodium Glycyrrhizate, Methyl Glycyrrhizate, and Potassium Glycyrrhizinate.
    Cosmetic Ingredient Review Expert Panel
    Int J Toxicol; 2007; 26 Suppl 2():79-112. PubMed ID: 17613133
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The use of non-animal alternatives in the safety evaluations of cosmetics ingredients by the Scientific Committee on Consumer Safety (SCCS).
    Vinardell MP
    Regul Toxicol Pharmacol; 2015 Mar; 71(2):198-204. PubMed ID: 25555996
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrated approaches to testing and assessment as a tool for the hazard assessment and risk characterization of cosmetic preservatives.
    Canavez ADPM; de Oliveira Prado Corrêa G; Isaac VLB; Schuck DC; Lorencini M
    J Appl Toxicol; 2021 Oct; 41(10):1687-1699. PubMed ID: 33624850
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety assessment of triethanolamine and triethanolamine-containing ingredients as used in cosmetics.
    Fiume MM; Heldreth B; Bergfeld WF; Belsito DV; Hill RA; Klaassen CD; Liebler D; Marks JG; Shank RC; Slaga TJ; Snyder PW; Andersen FA
    Int J Toxicol; 2013; 32(3 Suppl):59S-83S. PubMed ID: 23696578
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of alternative methods in the safety assessment of cosmetic ingredients.
    Rogiers V; Pauwels M
    Curr Probl Dermatol; 2008; 36():129-65. PubMed ID: 18806457
    [No Abstract]   [Full Text] [Related]  

  • 37. Safety Assessment of Alkyl Ethylhexanoates as Used in Cosmetics.
    Fiume M; Heldreth B; Bergfeld WF; Belsito DV; Hill RA; Klaassen CD; Liebler DC; Marks JG; Shank RC; Slaga TJ; Snyder PW; Andersen FA
    Int J Toxicol; 2015; 34(3 Suppl):61S-73S. PubMed ID: 26684798
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SpheraCosmolife: a new tool for the risk assessment of cosmetic products.
    Selvestrel G; Robino F; Baderna D; Manganelli S; Asturiol D; Manganaro A; Zanotti Russo M; Lavado G; Toma C; Roncaglioni A; Benfenati E
    ALTEX; 2021; 38(4):565-579. PubMed ID: 33963416
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk assessment of nanomaterials in cosmetics: a European union perspective.
    Henkler F; Tralau T; Tentschert J; Kneuer C; Haase A; Platzek T; Luch A; Götz ME
    Arch Toxicol; 2012 Nov; 86(11):1641-6. PubMed ID: 23052193
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amended Safety Assessment of Isethionate Salts as Used in Cosmetics.
    Burnett CL; Heldreth B; Bergfeld WF; Belsito DV; Hill RA; Klaassen CD; Liebler DC; Marks JG; Shank RC; Slaga TJ; Snyder PW; Andersen FA
    Int J Toxicol; 2017; 36(1_suppl):5S-16S. PubMed ID: 28553736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.